218 related articles for article (PubMed ID: 2650409)
1. Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry.
Ringdén O; Horowitz MM
Transplant Proc; 1989 Feb; 21(1 Pt 3):2989-92. PubMed ID: 2650409
[No Abstract] [Full Text] [Related]
2. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
Gale RP; Horowitz MM
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation for leukaemia in Europe.
Gratwohl A; Hermans J; Lyklema A; Zwaan FE
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):353-60. PubMed ID: 2480274
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation for the treatment of leukaemia-results of the Munich Cooperative Group.
Kolb HJ; Bender-Götze C; Haas RJ; Holler E; Thierfelder S; Wilmanns W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):397-402. PubMed ID: 2480280
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation for leukemia in Europe: regional differences. Report from the Leukemia Working party of the European Group for Bone Marrow Transplantation.
Gratwohl A; Hermans J; Barrett AJ; Ernst P; Frassoni F; Gahrton G; Granena A; Kolb HJ; Prentice HG; Vernant JP
Bone Marrow Transplant; 1990 Mar; 5(3):159-65. PubMed ID: 2331536
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Aschan J; Ringdén O
Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
[TBL] [Abstract][Full Text] [Related]
8. Current status of bone marrow transplantation in humans: report from the International Bone Marrow Transplant Registry.
Bortin MM; Horowitz MM; Gale RP
Nat Immun Cell Growth Regul; 1988; 7(5-6):334-50. PubMed ID: 3065641
[TBL] [Abstract][Full Text] [Related]
9. Importance of bone marrow cell dose in bone marrow transplantation.
Paulin T
Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation. The state of the art.
Thomas ED
Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
[No Abstract] [Full Text] [Related]
12. Allogeneic bone marrow transplantation from HLA-identical siblings following conditioning with busulfan and cyclophosphamide. First results.
Wiktor-Jedrzejczak W; Szczylik C; Matej H; Pojda Z; Ratajczak MZ; Myc A; Siekierzyński M; Kansy J; Kłos M; Rybicki Z
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):403-8. PubMed ID: 2480281
[TBL] [Abstract][Full Text] [Related]
13. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
Atkinson K; Downs K; Ashby M; Dodds A; Concannon A; Biggs J
Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplant in Belfast--an outcome overview of the first 25 years.
Cargo CA; Yates E; Marley C; Piggott S; McMullin MF; Jones FG
Ulster Med J; 2008 Sep; 77(3):185-90. PubMed ID: 18956801
[No Abstract] [Full Text] [Related]
15. Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT.
Hiraoka A; Shibata H; Masaoka T
Transplant Proc; 1992 Dec; 24(6):3047-8. PubMed ID: 1466051
[No Abstract] [Full Text] [Related]
16. Italian survey on allogeneic BMT for chronic myeloid leukaemia.
Arcese W; Mandelli F; Papa G; Bacigalupo A; Van Lint MT; Lucarelli G; Galimberti P; Polchi P; Tura S; Bandini G
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():90-1. PubMed ID: 2697445
[No Abstract] [Full Text] [Related]
17. Initial experiences in allogeneic bone marrow transplantation for leukaemias: report of National Institute of Haematology and Blood Transfusion (Hungary).
Poros A; Petrányi J; Harsányi V; Mód A; Bernyäk J; Hollán Z
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):409-11. PubMed ID: 2480282
[No Abstract] [Full Text] [Related]
18. Report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry.
Bone Marrow Transplant; 1989 May; 4(3):221-8. PubMed ID: 2659107
[TBL] [Abstract][Full Text] [Related]
19. An in vitro predictive test for clinical graft-versus-host disease in allogeneic bone marrow transplant recipients.
Sviland L; Dickinson AM; Carey PJ; Pearson AD; Proctor SJ
Bone Marrow Transplant; 1990 Feb; 5(2):105-9. PubMed ID: 1968774
[TBL] [Abstract][Full Text] [Related]
20. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.
Baker KS; Loberiza FR; Yu H; Cairo MS; Bolwell BJ; Bujan-Boza WA; Camitta BM; Garcia JJ; Ho WG; Liesveld JL; Maharaj D; Marks DI; Schultz KR; Wiernik P; Zander AR; Horowitz MM; Keating A; Weisdorf DJ
J Clin Oncol; 2005 Oct; 23(28):7032-42. PubMed ID: 16145067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
